DEST — Destiny Pharma Share News
0.000.00%
- £3.83m
- -£2.55m
REG - Destiny Pharma PLC - Notice of Interim Results
AnnouncementREG - Destiny Pharma PLC - Chair’s Investor Update
AnnouncementREG - Destiny Pharma PLC - Publication of new data on NTCD-M3
AnnouncementREG - Destiny Pharma PLC - Positive update from US FDA on XF-73 Phase 3
AnnouncementREG - Destiny Pharma PLC - Grant from the Cystic Fibrosis Foundation
AnnouncementREG - Destiny Pharma PLC - Publication of XF-73 drug synergy data
AnnouncementREG - Destiny Pharma PLC - New XF-73 research programme
AnnouncementREG - Destiny Pharma PLC - Grant of share options
AnnouncementREG - Destiny Pharma PLC - Result of Annual General Meeting & Strategy Update
AnnouncementREG - Destiny Pharma PLC - Board Changes
AnnouncementREG - Destiny Pharma PLC - Landmark NTCD-M3 data to be presented at Anaerobe
AnnouncementREG - Destiny Pharma PLC - Destiny Pharma appoints Dr Yuri Martina as CMO
AnnouncementREG - Destiny Pharma PLC - Posting of Annual Report and Notice of AGM
AnnouncementREG - Destiny Pharma PLC - Director/PDMR Shareholding
AnnouncementREG - Destiny Pharma PLC - Audited results for year ended 31 December 2021
AnnouncementREG - Destiny Pharma PLC - Notification of Major Holdings
AnnouncementREG - Destiny Pharma PLC - Notice of Results
AnnouncementREG - Destiny Pharma PLC - To present data at ECCMID Congress
AnnouncementREG - AIM - AIM Notice - 29/03/2022
Announcement